Advertisement
Screener

Zosano Pharma Corp Proceeds from Common Stock Issued

Zosano Pharma Corp Proceeds from Common Stock Issued

Zosano Pharma Corp reported Proceeds from Common Stock Issued of $19.25 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2019-11-14

  • Zosano Pharma Corp proceeds from issuance of common stock for the quarter ending 2019-09-30 was $778.00K, a 77700.00% increase year-over-year.
  • Zosano Pharma Corp proceeds from issuance of common stock for the quarter ending 2018-12-31 was $0.00.
  • Zosano Pharma Corp proceeds from issuance of common stock for the quarter ending 2018-09-30 was $1.00K.
  • Zosano Pharma Corp proceeds from issuance of common stock for the quarter ending 2018-06-30 was $19.00M.
  • Zosano Pharma Corp proceeds from issuance of common stock for fiscal 2018 was $45.60M, a 71.30% increase from fiscal 2017.
  • Zosano Pharma Corp proceeds from issuance of common stock for fiscal 2017 was $26.62M.
  • Zosano Pharma Corp proceeds from issuance of common stock for fiscal 2016 was $0.00.
Period endProceeds from Issuance of Common StockProceeds from Issuance of Common Stock 3 monthProceeds from Issuance of Common Stock 3 month as first filedProceeds from Issuance of Common Stock 6 monthProceeds from Issuance of Common Stock 9 monthProceeds from Issuance of Common Stock 12 month
2019-09-30$778.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$19.25M
10-Q · filed 2019-11-14
2019-06-30$18.47M
10-Q · filed 2019-08-14
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$1.00K
derived: sum of 2 quarters · filed 2019-11-14
$19.00M
derived: sum of 3 quarters · filed 2019-11-14
$45.60M
10-K · filed 2019-03-25
2018-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$19.00M
derived: sum of 2 quarters · filed 2019-11-14
$45.60M
10-Q · filed 2019-11-14
$45.60M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$19.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$45.60M
10-Q · filed 2019-08-14
$45.60M
derived: sum of 3 quarters · filed 2019-08-14
$45.60M
derived: sum of 4 quarters · filed 2019-08-14
2018-04-30$45.60M
10-Q · filed 2018-11-15
2018-04-03$45.60M
10-Q · filed 2018-11-15
2018-03-31$26.60M
10-Q · filed 2018-11-15
$0.00
10-Q · filed 2018-05-15
$26.60M
derived: sum of 2 quarters · filed 2019-03-25
$26.60M
derived: sum of 3 quarters · filed 2019-03-25
$26.60M
derived: sum of 4 quarters · filed 2019-03-25
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$0.00
derived: sum of 2 quarters · filed 2019-03-25
$0.00
derived: sum of 3 quarters · filed 2019-03-25
$26.62M
10-K · filed 2019-03-25
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-15
$0.00
derived: sum of 2 quarters · filed 2018-11-15
$26.62M
10-Q · filed 2018-11-15
$26.62M
derived: sum of 4 quarters · filed 2018-11-15
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$26.62M
10-Q · filed 2018-08-09
$26.62M
derived: sum of 3 quarters · filed 2018-08-09
$26.62M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$26.62M
10-Q · filed 2018-05-15
$26.62M
derived: sum of 2 quarters · filed 2018-05-15
$26.62M
derived: sum of 3 quarters · filed 2018-05-15
$26.62M
derived: sum of 4 quarters · filed 2018-05-15
2017-03-22$26.60M
10-K · filed 2019-03-25
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$0.00
derived: sum of 2 quarters · filed 2018-03-12
$0.00
derived: sum of 3 quarters · filed 2018-03-12
$0.00
10-K · filed 2018-03-12
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$0.00
derived: sum of 2 quarters · filed 2017-11-09
$0.00
10-Q · filed 2017-11-09
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$0.00
10-Q · filed 2017-08-10
2016-03-31$0.00
10-Q · filed 2017-05-09